What is NDC 80830-2435?

80830-2435 is the product NDC for Sodium Acetate, Sodium acetate anhydrous 164 mg/mL injection, solution, concentrate, listed with the FDA by Amneal Pharmaceuticals Private Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals Private Limited, NDC labeler code 80830. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sodium Acetate?

12 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sodium Acetate NDC 80830-2435 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)80830-2435Labeler and product segments. Claims need a package NDC.

Product NDC at billing width80830-2435Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
80830-2435-2	8083024350280830243502	25 BOTTLE, PLASTIC in 1 CARTON (80830-2435-2) / 20 mL in 1 BOTTLE, PLASTIC (80830-2435-1)Marketed from Mar 3, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Acetate
Generic name (nonproprietary): sodium acetate
Active ingredients: Sodium acetate anhydrous — 164 mg/mL
Dosage form: Injection, Solution, Concentrate
Route: Intravenous
Labeler: Amneal Pharmaceuticals Private LimitedNDC labeler code 80830
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218469
Marketing start: Mar 3, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 80830-2435_0006a5e7-aedf-40a7-9d69-c290ec63ffaaSPL ID 0006a5e7-aedf-40a7-9d69-c290ec63ffaaSPL set ID 0c0b11da-d7fc-4b4c-b0ef-d97af8e88abfRxCUI 1859490UNII NVG71ZZ7P0

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N480830243502 followed by a unit qualifier and the quantity

Package 80830-2435-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 21, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sodium acetate injection, 40 mEq is indicated as a source of sodium, for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 80830-2435

What is NDC 80830-2435?: 80830-2435 is the product NDC for Sodium Acetate, Sodium acetate anhydrous 164 mg/mL injection, solution, concentrate, listed with the FDA by Amneal Pharmaceuticals Private Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sodium Acetate.
What is the active ingredient?: Sodium acetate anhydrous.
Who is the labeler?: Amneal Pharmaceuticals Private Limited, NDC labeler code 80830. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sodium Acetate?: 12 other product NDCs are listed under this name. See all Sodium Acetate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sodium Acetate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sodium Acetate	Sodium acetate anhydrous 164 mg/mL	Injection, Solution, ConcentrateIntravenous	Amneal Pharmaceuticals Private Limited	80830-2436	80830-2436-02
Sodium Acetate	Sodium acetate anhydrous 164 mg/mL	Injection, Solution, ConcentrateIntravenous	Amneal Pharmaceuticals Private Limited	80830-2437	80830-2437-02
Sodium Acetate	Sodium acetate 164 mg/mL	Injection, Solution, ConcentrateIntravenous	MILLA PHARMACEUTICALS INC.	71357-002	71357-0002-10
Sodium Acetatesodium acetate injection, usp, 400 meq/100 ml	Sodium acetate 400 meq/100mL	Injection, Solution, ConcentrateIntravenous	MILLA PHARMACEUTICALS INC.	71357-009	71357-0009-10
Sodium Acetate	Sodium acetate 164 mg/mL	Injection, Solution, ConcentrateIntravenous	MILLA PHARMACEUTICALS INC.	71357-007	71357-0007-10
Sodium Acetatesodium acetate injection, usp, 200 meq/100 ml	Sodium acetate 200 meq/100mL	Injection, Solution, ConcentrateIntravenous	MILLA PHARMACEUTICALS INC.	71357-008	71357-0008-10
Sodium Acetate	Sodium acetate anhydrous 164 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0641-6261	00641-6261-01
Sodium Acetate	Sodium acetate anhydrous 164 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0641-6262	00641-6262-01
Sodium Acetate	Sodium acetate anhydrous 164 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0641-6263	00641-6263-10
Sodium Acetate	Sodium acetate 4 meq/100mL	Injection, Solution, ConcentrateIntravenous	Fresenius Kabi USA, LLC	63323-032	63323-0032-00

All 13 Sodium Acetate NDCs

Other NDCs under ANDA 218469

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218469
Product	Strength	Form · route	Labeler	Product NDC
Sodium Acetate	Sodium acetate anhydrous 164 mg/mL	Injection, Solution, ConcentrateIntravenous	Amneal Pharmaceuticals Private Limited	80830-2436
Sodium Acetate	Sodium acetate anhydrous 164 mg/mL	Injection, Solution, ConcentrateIntravenous	Amneal Pharmaceuticals Private Limited	80830-2437